The technology is genuinely useful for scientific discovery, but its applications are less dramatic than you might think.

Agilent Technologies Inc. (NYSE: A) announced today its participation at the American Association for Cancer Research (AACR) ...

IF YOU CANNOT DIAGNOSE BREAST CANCER AT AN EARLY ONSET ... FASHION TECHNOLOGY IN THE ARCHITECTURE DEPARTMENT. BIG IDEAS HAVE A WAY OF BREAKING OUT OF CONVENTIONAL BOUNDARIES.

and preclinical results from the Company's SMARCA2 monovalent direct degrader and CDK2 molecular glue degrader programs will be presented at the 2025 American Association for Cancer Research (AACR ...

today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...

today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...

today announced a poster regarding the Company's clinical asset, CT-95, a mesothelin ("MSLN”) x CD3 TCE will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2025, ...

Starton Therapeutics is a clinical-stage biotechnology platform company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer can ...

today announced four poster presentations at the American Association for Cancer Research (AACR) Annual Meeting 2025, taking place April 25-30, 2025, in Chicago, Illinois. Sapience will present ...